The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and medical costs of metastatic breast cancer care in the United States.
 
Rachel Jaber Chehayeb
No Relationships to Disclose
 
Annette Hood
Stock and Other Ownership Interests - Regeneron (I)
 
Sarah Schellhorn Mougalian
Stock and Other Ownership Interests - Coronado Biosciences; Gilead Sciences; Roche
Consulting or Advisory Role - Cardinal Health; Celgene; Eisai; Puma Biotechnology
Research Funding - Genentech; Pfizer
 
Maryam B. Lustberg
Honoraria - bioTheranostics; Novartis
Consulting or Advisory Role - Disarm Therapeutics; Pfizer; PledPharma
Other Relationship - Cynosure/Hologic
 
Shi-Yi Wang
Research Funding - Genentech (Inst)
 
Rachel Adams Greenup
Honoraria - Genentech; Novartis
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies
 
Natalia Kunst
No Relationships to Disclose